Managing Long-Term Follow-Up in Rare Disease Trials
Managing Long-Term Follow-Up in Rare Disease Trials Strategies for Sustaining Long-Term Follow-Up in Rare Disease Clinical Studies Why Long-Term Follow-Up Is Critical in Rare Disease Research Long-term follow-up (LTFU) is a vital component of rare disease clinical trials, particularly when therapies involve novel mechanisms such as gene therapy, enzyme replacement, or monoclonal antibodies. Given the…
Read More “Managing Long-Term Follow-Up in Rare Disease Trials” »